You are here: Home » News-IANS » Health-Medicine
Business Standard

Repurposing cancer drugs may help treat HPVs

IANS  |  New York 

Researchers have identified drugs that might be repurposed to treat caused by human papillomaviruses, or HPVs.

caused an estimated 266,000 deaths from cervical worldwide in 2012, according to the Routine screening by Pap smears or DNA tests has reduced death rates in developed countries compared to less developed regions of the globe.

Highly efficacious vaccines against exist -- including the recently approved Gardasil 9, which immunises against nine genotypes of HPV known to cause cervical, vulvar, vaginal and anal cancers, and But the vaccine needs to be given before a person becomes sexually active, since it has no therapeutic efficacy against existing HPV infections, the researchers said.

Preclinical experiments by researchers at University of at Birmingham (UAB) in the US suggest the drugs vorinostat, belinostat and panobinostat might help treat HPVs.

"Safe, effective and inexpensive therapeutic agents are urgently needed," said N. Sanjib Banerjee, at UAB.

In the study, detailed in the journal PNAS, the team discovered that the productive programme of HPV depends on differentiation of the epithelium into a full-thickness, squamous epithelium.

Furthermore, HPV reactivates host DNA replication in these differentiated cells such that the replication proteins and substrates become available to support viral

They found that vorinostat effectively slowed down HPV-18 DNA and production. Importantly, vorinostat also induced the programmed cell death in a fraction of the differentiated cells. Similar results were obtained with belinostat and panobinostat.

The UAB team also reported that vorinostat caused extensive cell death in raft cultures of dysplastic and cancer cell lines harbouring HPV-16.

HPV-16 and HPV-18 are the most prevalent, high-risk HPVs responsible for causing anogenital -- the cervix, penis and anus -- and oropharyngeal -- mouth and throat --

"But further investigation would be required to verify that these agents could also be useful in treating HPV associated dysplasias and cancers," Banerjee said.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sun, December 02 2018. 16:12 IST